Effects of immunological adjuvants on the mouse complement system. I. The inability of the polyanion heparin to act as an adjuvant is paralleled by inefficient alternative complement pathway inhibition

This publication has 23 references indexed in Scilit:

• Involvement of membrane-associated sialic acid in the resistance of sheep erythrocytes to lysis by mouse complement
  Immunology Letters, 1981
• Immunoglobulin-sulfated polysaccharide interactions. Binding of agaropectin and heparin by human IgG proteins.
  The Journal of Experimental Medicine, 1981
• The Alternative Pathway of Complement — A System for Host Resistance to Microbial Infection
  New England Journal of Medicine, 1980
• Heparin: An Old Drug with a New Paradigm
  Science, 1979
• Complement Components Detected on Normal Red Blood Cells Taken into EDTA and CPD¹
  Vox Sanguinis, 1979
• Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
  Journal of Clinical Investigation, 1979
• Killed Listeria monocytogenes vaccine becomes protective on addition of polyanions
  Nature, 1977
• Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement-III: Inhibition of C4 and C2 binding site(s) on C1s̄ by polyanions
  Immunochemistry, 1976
• Improvement of antisera against polypeptide hormones
  Nature, 1975
• CYTODYNAMICS OF THE IMMUNE RESPONSE IN TWO LINES OF MICE GENETICALLY SELECTED FOR "HIGH" AND "LOW" ANTIBODY SYNTHESIS
  The Journal of Experimental Medicine, 1972